McCarthy Tétrault advised Sagard Sagard Private Equity Canada in the investment. On October 6, 2023, Sagard Private Equity Canada completed its investment in the share capital...
You must be a Standard 1 Year member to access this content.
McCarthy Tétrault assisted Aptose Biosciences Inc. on the matter. On September 6, 2023, Aptose Biosciences Inc. announced the closing of a US$3 million investment in common shares...
You must be a Standard 1 Year member to access this content.
McCarthy Tétrault advised Glencore Canada Corporation on the sale. On July 14, 2023, Glencore Canada Corporation (“Glencore”) completed the sale of the 100% interest in its...
You must be a Standard 1 Year member to access this content.
McCarthy Tétrault advised Feldan on the deal. Feldan Bio Inc. (“Feldan”) completed a C$16.5 million Series B investment round that will see new investors Investissement Québec,...
You must be a Standard 1 Year member to access this content.
McCarthy Tétrault advised Oxio on the sale to Cogeco Connexion Inc. Cogeco Connexion announced the acquisition of the telecommunications operation of Internet service provider oxio, which will...
You must be a Standard 1 Year member to access this content.
McCarthy Tétrault advised Eight Capital and Desjardins Capital Markets on the deal. On January 25, 2023, Aya Gold & Silver closed their upsized offering of 11,151,550 common...
You must be a Standard 1 Year member to access this content.
McCarthy Tétrault assisted Aptose Biosciences Inc. on the deal. On December 12, 2022, Aptose Biosciences Inc. has entered into an equity distribution agreement with JonesTrading Institutional...
You must be a Standard 1 Year member to access this content.
McCarthy Tétrault advised APN World Inc. on the sale. Addleshaw Goddard advised DunPort Capital Management. On November 7, 2022, all of the issued and outstanding shares...
You must be a Standard 1 Year member to access this content.
McCarthy Tétrault advised Medicenna Therapeutics Corp. on the matter. On August 11, 2022, Medicenna Therapeutics Corp. closed its previously announced marketed underwritten public offering of units in Canada and in the United States for an...
You must be a Standard 1 Year member to access this content.
McCarthy Tétrault LLP advised the syndicate of agents on the issuance. On February 25, 2022, iA Financial Group closed an offering of C$300 million aggregate principal amount of...
You must be a Standard 1 Year member to access this content.
McCarthy Tétrault LLP advised Optel Vision on the acquisition. Optel Group, a world leader in supply chain traceability, has acquired the track-and-trace unit of the Körber Business Area...
You must be a Standard 1 Year member to access this content.
McCarthy Tétrault advised Aptose Biosciences on the deal. Aptose Biosciences Inc. has entered into an exclusive license agreement with Hanmi Pharmaceutical to develop and commercialize HM43239. Under the...
You must be a Standard 1 Year member to access this content.
